XML 30 R19.htm IDEA: XBRL DOCUMENT v3.25.1
STOCK OPTIONS
 3 Months Ended
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract]  
STOCK OPTIONS

NOTE 10 – STOCK OPTIONS

 

The following table presents the Company’s stock option activity for employees and directors of the Company for the three months ended March 31, 2025:

 

   Number of Options   Weighted Average Exercise Price 
Outstanding at December 31, 2024   29,217    15.38 
Granted   -    - 
Exercised   -    - 
Forfeited or expired   (1,294)   24.14 
Outstanding at March 31, 2025   27,923    14.97 
Number of options exercisable at March 31, 2025   17,923    23.33 

 

The aggregate intrinsic value of the awards outstanding as of March 31, 2025 was $236. These amounts represent the total intrinsic value, based on the Company’s stock price of $0.29 as of March 31, 2025, less the weighted exercise price. This represents the potential amount received by the option holders had all option holders exercised their options as of that date.

 

Costs incurred in respect of stock-options compensation for employees and directors for the three months ended March 31, 2025 and 2024 were less than $1 and $0, respectively.